1 / 1

NIH Consensus Development Conference: Inhaled Nitric Oxide Therapy for Premature Infants

NIH Consensus Development Conference: Inhaled Nitric Oxide Therapy for Premature Infants. F. Sessions Cole, M.D. Panel and Conference Chairperson.

tashya-willis
Télécharger la présentation

NIH Consensus Development Conference: Inhaled Nitric Oxide Therapy for Premature Infants

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. NIH Consensus Development Conference:Inhaled Nitric Oxide Therapy for Premature Infants F. Sessions Cole, M.D. Panel and Conference Chairperson Dr. Cole is the Park J. White, M.D. Professor of Pediatrics, Vice Chancellor for Children’s Health, and Vice Chairperson for the Department of Pediatrics, and the Director of the Division of Newborn Medicine at the Washington University School of Medicine. He is also the Chief Medical Officer of the St. Louis Children’s Hospital. Dr. Cole’s research interests focus on understanding the genetic mechanisms that disrupt pulmonary surfactant metabolism and cause neonatal respiratory distress syndrome.

More Related